News | ECG | February 16, 2021

New ECG System Eliminated Wire Leads to Simlify Standard 12-Lead ECG 

Company says it reduces patient contact during the COVID-19 pandemic and is the world’s first 12-lead ECG service for home use

The QT Medical PCA 500 12-lead ECG system uses a unique wearable wrap that contains all the leads and eliminated the need to connect separate wire electrodes to the patient. The simplicfication of lead placement enables the system to be used by patients at home.

The QT Medical PCA 500 12-lead ECG system uses a unique wearable wrap that contains all the leads and eliminated the need to connect separate wire electrodes to the patient. The simplicfication of lead placement enables the system to be used by patients at home.

February 16, 2021 — QT Medical recently announced the launch of Xpress ECG service, the world’s first 12-lead ECG home test, to help reduce the risk of exposure to COVID-19 by bringing ECG tests to patients’ homes. The 12-lead ECG (EKG) with PCA 500 and makes it available for use by both healthcare professionals and patients. 

In response to the surge of needs in the COVID-19 pandemic, the company offers Xpress ECG service, which makes ECG tests accessible and affordable, while decreasing the risk of exposure to potential infections. The physicians can now simply order Xpress ECG tests online and the ECG kits will be shipped to the patients in 1 to 3 business days.

The ECG tests are performed using PCA 500, a complete 12-lead ECG platform that includes a super-compact recorder, prepositioned electrode strip, mobile app, HIPAA-compliant cloud and preliminary interpretation. 

“This new exclusive service offers patients the ability to monitor their own heart health, allows healthcare providers to continue providing quality of care while maximizing revenue, and minimizing cost and risks for the healthcare system. Xpress ECG enables millions of patients with heart diseases to manage their health from the comfort of their homes,” said Ruey-Kang Chang, M.D., CEO of QT Medical Inc.

With the new CPT codes (e.g. 99457), an ECG test done by patients at home can be reimbursed 3 times higher than an ECG test done in the doctor’s office. When the doctor orders an Xpress ECG test, a kit including a PCA 500 recorder, an electrode strip, and a postage-paid return envelope will be shipped to the patients. QT Medical had previously conducted a clinical trial, which showed minimal or no training is needed to use PCA 500. All ECGs are automatically transmitted to the cloud, and a preliminary computer interpretation is instantly available. Through the cloud, physicians can review the results from anywhere to make informed decisions.

Unlike dozens of single lead ECG devices on the market, PCA 500 is hospital grade 12-lead ECG, which is medical standard for diagnosing a wide variety of heart diseases such as heart attacks, long QT syndrome, myocarditis, adverse effects of medications, cardiomyopathy, etc. Using Xpress ECG, healthcare providers can minimize the risk of infection by not sending patients to labs or hospitals for ECG tests. Telehealth patients who need an ECG test will be able to get a full 12-lead ECG without leaving their homes.

Xpress ECG is a medical standard 12-lead ECG test, using PCA 500, ordered by healthcare providers. Patients should consult their physicians to decide if PCA 500 is right for them.

QT Medical is a medtech company with a focus on high quality 12-lead diagnostic ECG for use by healthcare professionals and patients. Cleared by the FDA in 2018 and CE marked in 2020, PCA 500 is the world’s most compact 12-lead ECG system. With its simplicity, ease of use, mobile technology and cloud management, PCA 500 brings hospital-grade ECG to homes, and enables doctors to make informed decisions anywhere, anytime. 

For more information: www.qtmedical.com

Related Content

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images

News | Cardiac Diagnostics | February 02, 2021
February 2, 2021 — A new study has found in the U.S.
A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

News | Cardiac Diagnostics | January 06, 2021
January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc.
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en
heart disease image
News | Cardiac Diagnostics | December 18, 2019
December 18, 2019 — In their latest report, “...
FDA Warns Troponin Tests Impacted by Biotin Dietary Supplement
Feature | Cardiac Diagnostics | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — The U.S.
Videos | Cardiac Diagnostics | October 29, 2019
Doctor Clyde Yancy was a keynote speaker and said doctors need to check their assumptions about patients at the door...
79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event

79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event. Image courtesy of University Hospitals.

News | Cardiac Diagnostics | October 16, 2019
Health and wellness screenings are more than just nice events for the community – they can save lives. A Mentor, Ohio,...